Imaging Drug Resistance with Radiolabeled Molecules

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|24|2965-2979

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.24, 2004-09, pp. : 2965-2979

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Metastatic Carcinoid Tumors With Radiolabeled Biologic Molecules

By Bushnell David  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 7, Iss. 7, 2009-07 ,pp. : 760-764

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Design of New Drug Molecules to be Used in Reversing Multidrug Resistance in Cancer Cells

By  

Current Cancer Drug Targets, Vol. 9, Iss. 3, 2009-05 ,pp. : 298-306

Bentham Science Publishers

Access to resources Recommend Favorite

Radiolabeled Imaging Probes Targeting Angiogenesis for Personalized Medicine

By  

Current Pharmaceutical Design, Vol. 20, Iss. 14, 2014-01 ,pp. : 2293-2307

Bentham Science Publishers

Access to resources Recommend Favorite

Radiolabeled Sugars Used for PET and SPECT Imaging

By  

Current Radiopharmaceuticals, Vol. 9, Iss. 3, 2016-12 ,pp. : 180-186

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Radiolabeled Compounds for Myocardial Perfusion Imaging

By  

Current Pharmaceutical Design, Vol. 18, Iss. 8, 2012-03 ,pp. : 1041-1057

Bentham Science Publishers

Access to resources Recommend Favorite